Exploring Strategies for Personalized Radiation Therapy Part II Predicting Tumor Drift Patterns with Diffusion Models

• URL: http://arxiv.org/abs/2506.17491v1
• Date: Fri, 20 Jun 2025 21:58:42 GMT
• Title: Exploring Strategies for Personalized Radiation Therapy Part II Predicting Tumor Drift Patterns with Diffusion Models
• Authors: Hao Peng, Steve Jiang, Robert Timmerman,
• Abstract summary: We propose a novel framework using Denoising Diffusion Implicit Models (DDIM), which learns data-driven mappings from pre to post treatment imaging.<n>Results show that diffusion models can effectively simulate patient specific tumor evolution and localize regions associated with treatment response.
• Score: 17.401088816596054
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Radiation therapy outcomes are decided by two key parameters, dose and timing, whose best values vary substantially across patients. This variability is especially critical in the treatment of brain cancer, where fractionated or staged stereotactic radiosurgery improves safety compared to single fraction approaches, but complicates the ability to predict treatment response. To address this challenge, we employ Personalized Ultra-fractionated Stereotactic Adaptive Radiotherapy (PULSAR), a strategy that dynamically adjusts treatment based on how each tumor evolves over time. However, the success of PULSAR and other adaptive approaches depends on predictive tools that can guide early treatment decisions and avoid both overtreatment and undertreatment. However, current radiomics and dosiomics models offer limited insight into the evolving spatial and temporal patterns of tumor response. To overcome these limitations, we propose a novel framework using Denoising Diffusion Implicit Models (DDIM), which learns data-driven mappings from pre to post treatment imaging. In this study, we developed single step and iterative denoising strategies and compared their performance. The results show that diffusion models can effectively simulate patient specific tumor evolution and localize regions associated with treatment response. The proposed strategy provides a promising foundation for modeling heterogeneous treatment response and enabling early, adaptive interventions, paving the way toward more personalized and biologically informed radiotherapy.

Related papers

• Exploring Strategies for Personalized Radiation Therapy Part I Unlocking Response-Related Tumor Subregions with Class Activation Mapping [17.401088816596054]
  This study compares three approaches for predicting treatment response: standard radiomics, gradient based features, and convolutional neural networks enhanced with Class Activation Mapping.<n>We analyzed 69 brain metastases from 39 patients treated with Gamma Knife radiosurgery.<n> Pixel wise CAM outperformed both radiomics and gradient based methods in classification accuracy.
  arXiv  Detail & Related papers  (2025-06-21T01:24:25Z)
• Medical World Model: Generative Simulation of Tumor Evolution for Treatment Planning [50.16114813279694]
  We introduce the Medical World Model (MeWM), the first world model in medicine that visually predicts future disease states based on clinical decisions.<n>MeWM comprises (i) vision-language models to serve as policy models, and (ii) tumor generative models as dynamics models.<n>We propose the inverse dynamics model that applies survival analysis to the simulated post-treatment tumor, enabling the evaluation of treatment efficacy and the selection of the optimal clinical action plan.
  arXiv  Detail & Related papers  (2025-06-02T23:50:40Z)
• Transforming Multimodal Models into Action Models for Radiotherapy [39.682133213072554]
  Radiotherapy a crucial cancer treatment demands precise planning to balance tumor preservation and eradication of healthy tissue.<n>Traditional treatment planning (TP) is iterative, time-consuming, and reliant on human expertise.<n>We propose a novel framework to transform a multimodal foundation model (MLM) into an action model for using a few-shot reinforcement learning approach.
  arXiv  Detail & Related papers  (2025-02-06T09:51:28Z)
• A Learnable Prior Improves Inverse Tumor Growth Modeling [8.87818392404259]
  We propose a novel framework that leverages the unique strengths of both approaches in a synergistic manner. We showcase the effectiveness of integrating a rapid deep-learning algorithm with a high-precision evolution strategy in estimating brain tumor cell concentrations from magnetic resonance images.
  arXiv  Detail & Related papers  (2024-03-07T13:59:34Z)
• Treatment-wise Glioblastoma Survival Inference with Multi-parametric Preoperative MRI [34.830878479276286]
  We propose a treatment-conditioned regression model for glioblastoma ST that incorporates treatment information in addition to MR scans. Our approach allows us to effectively utilize the data from all of the treatments in a unified manner, rather than having to train separate models for each of the treatments.
  arXiv  Detail & Related papers  (2024-02-10T16:13:09Z)
• Deep learning methods for drug response prediction in cancer: predominant and emerging trends [50.281853616905416]
  Exploiting computational predictive models to study and treat cancer holds great promise in improving drug development and personalized design of treatment plans. A wave of recent papers demonstrates promising results in predicting cancer response to drug treatments while utilizing deep learning methods. This review allows to better understand the current state of the field and identify major challenges and promising solution paths.
  arXiv  Detail & Related papers  (2022-11-18T03:26:31Z)
• Benchmarking Heterogeneous Treatment Effect Models through the Lens of Interpretability [82.29775890542967]
  Estimating personalized effects of treatments is a complex, yet pervasive problem. Recent developments in the machine learning literature on heterogeneous treatment effect estimation gave rise to many sophisticated, but opaque, tools. We use post-hoc feature importance methods to identify features that influence the model's predictions.
  arXiv  Detail & Related papers  (2022-06-16T17:59:05Z)
• RadioPathomics: Multimodal Learning in Non-Small Cell Lung Cancer for Adaptive Radiotherapy [1.8161758803237067]
  We develop a multimodal late fusion approach to predict radiation therapy outcomes for non-small-cell lung cancer patients. Experiments show that the proposed multimodal paradigm with an AUC equal to $90.9%$ outperforms each unimodal approach.
  arXiv  Detail & Related papers  (2022-04-26T16:32:52Z)
• MIA-Prognosis: A Deep Learning Framework to Predict Therapy Response [58.0291320452122]
  This paper aims at a unified deep learning approach to predict patient prognosis and therapy response. We formalize the prognosis modeling as a multi-modal asynchronous time series classification task. Our predictive model could further stratify low-risk and high-risk patients in terms of long-term survival.
  arXiv  Detail & Related papers  (2020-10-08T15:30:17Z)
• DTR Bandit: Learning to Make Response-Adaptive Decisions With Low Regret [59.81290762273153]
  Dynamic treatment regimes (DTRs) are personalized, adaptive, multi-stage treatment plans that adapt treatment decisions to an individual's initial features and to intermediate outcomes and features at each subsequent stage. We propose a novel algorithm that, by carefully balancing exploration and exploitation, is guaranteed to achieve rate-optimal regret when the transition and reward models are linear.
  arXiv  Detail & Related papers  (2020-05-06T13:03:42Z)
• Estimating Counterfactual Treatment Outcomes over Time Through Adversarially Balanced Representations [114.16762407465427]
  We introduce the Counterfactual Recurrent Network (CRN) to estimate treatment effects over time. CRN uses domain adversarial training to build balancing representations of the patient history. We show how our model achieves lower error in estimating counterfactuals and in choosing the correct treatment and timing of treatment.
  arXiv  Detail & Related papers  (2020-02-10T20:47:36Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.